You must be reading my mind, I just posted that and then took it down when i seen yours, Too funny
Heres the link
PLoS One. 2015 Mar 18;10(3):e0119160. doi: 10.1371/journal.pone.0119160.
Heinz. You've got that right, People are frustrated and with good cause.
I know that IF this company is in talks with Abbott or anyone else, I understand their silence, But it doesn't ease the frustration that all of us shareholders feel.
jomar, Anythings possible, Last year they filed the 10K in the middle of the month, But MOST of the other 10K filings were done at the end of the month.
Ameritrade had it listed to be filed on the 18th ( CONFIRMED ) but it looks like thats not gonna happen.
I just looked and its still there
BG Medicine Inc Q4 2014 $-0.05 E $-0.05 to $-0.05 16.67% 1
This boy is a few cards short of a full deck, He has since deleated the post, But I knew he would and made a copy of it.
(( LILY and JESS if you died today and God looked at your posts with the intentions of your Heart will you enter heaven or go to HELL I would say the later ))
Doesn't look good !!!!!
Jess, Looks like King is using all his Yahoo names to give you 5 thumbs down, Did you hear he had a dream about this going to $3.90.
And here I thought that it was Dr. Martin Luther King who had a dream !!!!!
About 30 percent of people in the U.S. now suffer from fatty liver diseases, such as NASH nonalcoholic steatohepatitis. fueled by obesity, diabetes and over-indulgent lifestyles, according to the American Liver Foundation. Without treatment, sufferers can develop advanced damage, including the scarring known as fibrosis; cirrhosis, which destroys liver function; and even cancer.
Some of the new techniques use MRI scans that view the entire liver. Others involve blood tests to measure liver scarring or function.
The U.S. Food and Drug Administration declined to discuss tests in development. The agency "supports innovation, especially where new tests and diagnostic procedures might eliminate or decrease the need for an invasive procedure such as a liver biopsy," a spokesman said.
Background The identification of cancer biomarkers can advance the possibility for early detection and better monitoring of tumor progression. The aim of this study was to assess the diagnostic and prognostic value of serum galectin-3Gal-3 in patients with gastric cancer GC. Material and Methods We measured serum Gal-3 levels using ELISA method in 87 patients with GC, 53 patients with benign gastric lesions, and 51 healthy controls. Results Serum levels of Gal-3 in patients with GC were significantly higher than those in benign disease patients and healthy controls P
King, This is what you're posting now, DREAMS
Galectin 3 A NEW MARKER OF HEART FAILURE COMING SOON Galectin 3 is a marker of activation of myocardial fibrosis which is the cause of ventricular dysfunction in 30-50% of patients with chronic heart failure. Galectin 3 presents a significant clinical interest, reflecting the evolution of deep and long-term mechanism of heart failure. Galectin 3 complements the more instantaneous information on the status of patient data given by natriuretic peptides. Galectin 3 has a strong predictive potential of the development of the disease, to identify high-risk patients and their implementing taken specific charges. This new full marker panel ARCHITECT cardiac biomarkers BNP, cTnI hs etc..
This issue about the Nasdaq letter IMHO is a non issue, With the ammunition BGMD Has to go before the board and ask for the 180 extension is just about a sure thing, 85 pct of companies that ask for the extension get it.
All BGMD Has to do is show them the FDA CLEARANCE and their relationship with ABBOTT, DONE DEAL
No it would not have happened, They will first try and get this over $1.00 for 10 days and sell Aspire the $12M in stocks, Thats the backup plan, And that plan may start next week, If it dosent BGMD will run out of cash in april and it WILL do a reverse split if they dont come to some agreement with Abbott.
Dont bury your heade in the sand, Look at both sides of the coin, The split is not the end of the world, all it means is you'll all be here a lot longer then you expected, But the outcome will be the same.
are correct travelingfam4, There are many opinions as to what can happen here.
Problem here is the folks that run the company, Not the technology.
As for a shelf bring filed, I don think so. The Aspire deal is set if we can get over $1.00. We can sell them up to $12M in shares.
The problem longs have here is the lack of transparency with this company. None or most of the things we argue about could easily be solved in only the could throw the shareholders a bone, I don't think that would be asking too much, Anyway , We should all know what's going on with earnings next week, It they don't report next week, OH BOY Rumors will fly. Now that'll be fun to see.
There's an intellectual for you.
Jess, You and I know that there are a few things that will stop this company from doing a reverse split.
1 - They get an upfront payment from Abbott. Nobody knows what their agreement is yet, So that's up in the air.
2- They get this over a dollar for ten days and sell $12M to Aspire. That's Dilution
3 - Abbott buys them out.
4 - Do a Reverse Split, Most likely without some cash.
They are not IMO going to have good , Or even equal Revs to Q3 so that's a moot point.
They will run out of cash by the end of April, That's a fact without an infusion of cash.
IMO , I don't think they will see any earnings from the Automated Assay this year, So at the very least amount of cash they'll need would be $12M
There are few options here, You do.the math.
That reply was about someone making a stupid statement that the stock runs on Friday, That was B/S, Just a minute of time was spent to check and see if that were the case, AND it wasn't, Whats wrong with calling someone out on a B/S post ???
WHAT !!!!!!! Out of the last 14 trading weeks, There has been only 1 up Friday 10 down and 3 even, You couldn't be more wrong